ENDRA Life Sciences (NDRA) Tops Q3 EPS by 1c; Reports Cash and Cash Equivalents of $11.8M

ENDRA Life Sciences (NASDAQ: NDRA) reported Q3 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
• KULR Technology Group (KULR) Misses Q2 EPS by 39c